PRESS-RELEASE ·Filed May 8, 2026
Press release: activist
Actionable Insight • Neutral
No trading action warranted. Monitor upcoming Phase 3 data for cadisegliatin as primary catalyst.
Final — all horizons settled through T+60d
VTVT ▲ +12.90% at T+60d
NEUTRAL call ✓ call won +12.90% · α vs SPY +8.51% · entry $30.46 → $34.39
T+1d
+5.42%
call +5.42% · α +5.55%
$32.11
settled 5mo ago
T+5d
+16.51%
call +16.51% · α +16.60%
$35.49
settled 5mo ago
T+20d
+4.30%
call +4.30% · α +4.61%
$31.77
settled 4mo ago
T+60d
+12.90%
call +12.90% · α +8.51%
$34.39
settled 8w ago
Price Chart
Loading chart...
Executive Summary
vTv Therapeutics granted 39,500 stock options to two non-executive employees as inducement awards. This is a routine compensation event with no material impact on the company's operations or financials.
Key Facts
- 39,500 stock options granted to two non-executive employees
- Weighted average exercise price of $32.00 per share
- Options vest over 4 years with 25% cliff at one year
- Options have a 10-year term
Financial Impact
Minimal; options represent less than 0.5% of outstanding shares (assuming ~10M shares outstanding)
dilution
Risk Factors
- Dilution from options is negligible
- No change to clinical or regulatory outlook
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
91% bullish (11 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3291335 |
4 reports for VTVT
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 10, 2026 16w ago | DEFA14A | $31.59 $33.35 | ▲ +5.57% | ▲ +1.18% | $31.36 (−0.73%) |
May 8, 2026 20w ago | Press Release | $30.46 $34.39 | ▲ +12.90% | ▲ +8.51% | $31.36 (+2.95%) |
Mar 10, 2026 29w ago | Press Release | $35.10 $32.94 | ▼ −6.15% | ▼ −17.68% | $31.36 (−10.66%) |
Feb 26, 2026 31w ago | 8-K | $39.32 $35.50 | ▼ −9.72% | ▼ −17.47% | $31.36 (−20.24%) |
Showing 4 of 4
US Market Status
Market Open — Closes in 3h 40m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access